Post-traumatic Stress Disorder Treatment Market Share

  • Report ID: 6496
  • Published Date: Oct 01, 2024
  • Report Format: PDF, PPT

Post-traumatic Stress Disorder Treatment Market Share

North America Market Statistics

The post-traumatic stress disorder (PTSD) treatment market in North America is anticipated to hold the largest share of 40.7% by the end of 2037. The market growth is expected on account of the high rate of PTSD prevalence and the rising need for mental health care. PTSD affects a significant portion of population in the region, including veterans, first responders, and survivors of trauma, leading to increased demand for effective treatments.

The PTSD treatment market is expanding in the U.S. due to several factors, including rising government financing for mental health programs, increased awareness of the value of mental health, and an increase in the number of mental health practitioners. Also, there is a rising shift towards positivity among people regarding mental health. According to a 2019 survey by the American Psychological Association, 87% of adults in the U.S. concur that having a mental health illness is nothing to be ashamed of, and 86% stated that they think people with mental health illnesses are capable of recovering.

In Canada, the funding of mental health services and programs has increased since the government declared mental health a high priority. For instance, in 2023, the Canadian Institutes of Health Research (CIHR) funded 25 research projects with about USD 5 million to investigate current norms, best practices, and policies for providing mental health and drug-use services to teenagers, children, and young people. Furthermore, the market is expanding due to the rising demand for mental health services and the availability of cutting-edge therapies such as virtual reality therapy.

Europe Market Analysis

The PTSD treatment market in Europe will hold the second-largest revenue share during the forecast period. The market is growing in the region owing to the increasing incidences of PTSD and surging demand for mental health services. For instance, the majority of people in Europe roughly two-thirds have at least one traumatic incident in their lifetime.

The UK post-traumatic stress disorder (PTSD) treatment market is expanding due to several factors, including rising government funding for mental health initiatives, expanding awareness of the value of mental health, and the accessibility of cutting-edge therapies that include, Eye Movement Desensitization and Reprocessing (EMDR). The government stated that by April 2024, an additional USD 2.57 billion in funding will be provided annually to expand and reform mental health services in England, enabling 2 million more individuals to receive the necessary mental health assistance.

In Germany, improving the nation's mental health and quality of life are top priorities. The need for efficient therapies is driven by the emphasis on mental health as a vital aspect of total well-being. The industry is expanding due to the initiatives to improve mental health care and promote wellbeing.

Research Nester
Post-traumatic Stress Disorder Treatment Market size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6496
  • Published Date: Oct 01, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of PTSD treatment was over USD 17.7 billion.

The market size for post-traumatic stress disorder (PTSD) treatment is projected to cross USD 35.1 billion by the end of 2037 expanding at a CAGR of 5.4% during the forecast period i.e., between 2025-2037.

The major players in the market are Jazz Pharmaceuticals plc, Bionomics Limited, Merck KGaA, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc (GSK plc), Viatris Inc., Jubilant Pharmova Ltd., H. Lundbeck A/S, Camber Pharmaceuticals, Inc., and others.

The adult segment is anticipated to garner a share/size of 84.7% % during 2025-2037.

The North America post-traumatic stress disorder (PTSD) treatment sector is poised to hold a 40.7% share by the end of 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample